Open access · CC-BY
via OpenAlex
Stem cell therapies in preclinical models of stroke associated with aging
Aurel Popa‐Wagner, Ana-Maria Buga, Thorsten Roland Doeppner, Dirk Matthias Hermann
Frontiers in Cellular Neuroscience · 2014 · ▲ 65 citations
Abstract
Stroke has limited treatment options, demanding a vigorous search for new therapeutic strategies. Initial enthusiasm to stimulate restorative processes in the ischemic brain by means of cell-based therapies has meanwhile converted into a more balanced view recognizing impediments related to unfavorable environments that are in part related to aging processes. Since stroke afflicts mostly the elderly, it is highly desirable and clinically important to test the efficacy of cell therapies in aged brain microenvironments. Although widely believed to be refractory to regeneration, recent studies using both neural precursor cells and bone marrow-derived mesenchymal stem cells for stroke therapy suggest that the aged rat brain is not refractory to cell-based therapy, and that it also supports plasticity and remodeling. Yet, important differences exist in the aged compared with young brain, i.e., the accelerated progression of ischemic injury to brain infarction, the reduced rate of endogenous neurogenesis and the delayed initiation of neurological recovery. Pitfalls in the development of cell-based therapies may also be related to age-associated comorbidities, e.g., diabetes or hyperlipidemia, which may result in maladaptive or compromised brain remodeling, respectively. These age-related aspects should be carefully considered in the clinical translation of restorative therapies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fncel.2014.00347
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Popa‐Wagner, A., Buga, A., Doeppner, T.R., & Hermann, D.M. (2014). Stem cell therapies in preclinical models of stroke associated with aging. <em>Frontiers in Cellular Neuroscience</em>. https://doi.org/10.3389/fncel.2014.00347
Vancouver
Popa‐Wagner A, Buga A, Doeppner TR, Hermann DM. Stem cell therapies in preclinical models of stroke associated with aging. Frontiers in Cellular Neuroscience. 2014. doi:10.3389/fncel.2014.00347.
BibTeX
@article{aurel2014Stemce,
title = {Stem cell therapies in preclinical models of stroke associated with aging},
author = {Aurel Popa‐Wagner and Ana-Maria Buga and Thorsten Roland Doeppner and Dirk Matthias Hermann},
journal = {Frontiers in Cellular Neuroscience},
year = {2014},
doi = {10.3389/fncel.2014.00347},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell stem cell 2017
Open access · OA
Rejuvenating Strategies for Stem Cell-Based Therapies in Aging
Frontiers in Aging Neuroscience 2015
Open access · CC-BY
Forever young: rejuvenating muscle satellite cells
Cell Cycle 2012
Open access · OA
Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches
Aging and Disease 2024
Open access · CC-BY
Ischemic Stroke and the Biological Hallmarks of Aging
PubMed 2024
Preprint · CC-BY
Ischemic Stroke and the Biological Hallmarks of Aging.
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY